Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ndiémé Ndongo"'
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Objective: Rheumatoid arthritis (RA) leads not only to joint destruction but also to systemic manifestations, with an increased incidence of cardiovascular events (CVE). Many studies have shown a link between RA severity and CV risk, but the duration
Externí odkaz:
https://doaj.org/article/a1cbbbc823f0491ba9b67a7470f7f842
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Rheumatoid arthritis (RA) remains a cause of morbidity and mortality in many patients while new treatments have changed the face of the disease. Despite the emergence of these new drugs, cardiovascular (CV) diseases remain more frequent in RA patient
Externí odkaz:
https://doaj.org/article/cdf1b7cc0d9c4decbda7cff1e49bf444
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
The production and function of cytokines are highly regulated. One mechanism is the balance between pro- and anti-inflammatory cytokines. As interleukin (IL)-17A and IL-25 share the IL-17RA receptor chain, we hypothesize that IL-25 acts as an IL-17A
Externí odkaz:
https://doaj.org/article/12374547beab4b2b902158c4225b7e18
Publikováno v:
Clinical and Experimental Immunology. 186:64-74
Summary In the context of psoriasis, T helper type 17 (Th17) cells infiltrate the inflammatory site and interact with local mesenchymal cells, including skin fibroblasts. The aim of this work was to study the interactions of skin-derived fibroblasts
Publikováno v:
Annals of the Rheumatic Diseases. 75:1420-1422
Autoantibodies against proinflammatory cytokines1 such as interleukin (IL)-1α are protective and a marker of good prognosis in rheumatoid arthritis (RA).2 ,3 They bind their antigen, that is, the cytokine, forming immune complexes (ICs). IL-17 is a
Publikováno v:
Immune regulation.
Background During rheumatoid arthritis (RA), steroids and biotherapies are two different ways to diminish inflammation, by reducing cytokine production and they are used alone and combined. Their efficacy has been established in clinical trials but t
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Background: During rheumatoid arthritis (RA), steroids and biotherapies are used alone and combined. Efficacy has been established in clinical trials but their differential effects at the cellular level are less documented. The aim was to study these
Publikováno v:
Frontiers in Immunology
Background During rheumatoid arthritis (RA), steroids and biotherapies are used alone and combined. Efficacy has been established in clinical trials but their differential effects at the cellular level are less documented. The aim was to study these
Autor:
Ndiémé Ndongo, Sylvie De Sequeira, Yassine Rechoum, Christian Trepo, Emmanuel Drouet, Fabien Zoulim, Marie-Anne Petit
Publikováno v:
Journal of Medical Virology. 81:1726-1733
The aim of this study was to determine the inhibition of binding activity of the monoclonal antibody (mAb) D32.10 which recognizes a highly conserved discontinuous antigenic determinant (E1:297-306, E2:480-494, and E2:613-621) expressed on the surfac
Autor:
Cyril Clavel, Guy Serre, Géraldine Offer, Mireille Sebbag, Lætitia Laurent, Pierre Miossec, Florence Anquetil, JL Pasquali, Ndiémé Ndongo-Thiam
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2015, 74 (7), pp.1425-1431. ⟨10.1136/annrheumdis-2013-204543⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2015, 74 (7), pp.1425-1431. ⟨10.1136/annrheumdis-2013-204543⟩
ObjectivesAnticitrullinated protein antibodies (ACPA) are specifically associated with rheumatoid arthritis (RA) and produced in inflamed synovial membranes where citrullinated fibrin, their antigenic target, is abundant. We showed that immune comple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26795e3e4daf3fac3e33225e8bafbcdb
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03154842
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03154842